Brii Biosciences Public

We innovate and advance novel therapies to provide greater choice and freedom to broad patient populations.
Brii Biosciences is a biotechnology company developing therapies to address some of the world’s most common public health challenges where patients experience high unmet medical needs, limited choice and significant social stigmas. With a focus on infectious diseases and central nervous system diseases, we have built a robust pipeline of potential treatment options based on patient insights and experiences, and are advancing these differentiated investigational therapies to address patient choice.


Investors

Technology: COVID
Headquarters: United States
Funding Status: N/A
Investment Stage: N/A
Founded Date: 2018-01-01
Number Of Exists: N/A
Last Funding Type: Venture - Series Unknown
Investors Number: 6
Last Funding Date: 2018-05-24
Employee Number: N/A
Total Funding: 260000000 USD
Industry: PharmTech
Investor Type: N/A